KYMR
Price
$44.79
Change
+$0.26 (+0.58%)
Updated
Jul 3 closing price
Capitalization
3.14B
26 days until earnings call
LYRA
Price
$9.00
Change
-$0.31 (-3.33%)
Updated
Jul 3 closing price
Capitalization
15.74M
37 days until earnings call
Interact to see
Advertisement

KYMR vs LYRA

Header iconKYMR vs LYRA Comparison
Open Charts KYMR vs LYRABanner chart's image
Kymera Therapeutics
Price$44.79
Change+$0.26 (+0.58%)
Volume$240.49K
Capitalization3.14B
Lyra Therapeutics
Price$9.00
Change-$0.31 (-3.33%)
Volume$43.49K
Capitalization15.74M
KYMR vs LYRA Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. LYRA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and LYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (KYMR: $44.79 vs. LYRA: $9.00)
Brand notoriety: KYMR and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 25% vs. LYRA: 5%
Market capitalization -- KYMR: $3.14B vs. LYRA: $15.74M
KYMR [@Biotechnology] is valued at $3.14B. LYRA’s [@Biotechnology] market capitalization is $15.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, LYRA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while LYRA’s TA Score has 2 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 4 bearish.
  • LYRA’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than LYRA.

Price Growth

KYMR (@Biotechnology) experienced а -2.01% price change this week, while LYRA (@Biotechnology) price change was -32.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.14B) has a higher market cap than LYRA($15.7M). KYMR YTD gains are higher at: 11.335 vs. LYRA (-12.791). LYRA has higher annual earnings (EBITDA): -44.7M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. LYRA (31.7M). LYRA has less debt than KYMR: LYRA (33.4M) vs KYMR (86.3M). KYMR has higher revenues than LYRA: KYMR (58.9M) vs LYRA (1.19M).
KYMRLYRAKYMR / LYRA
Capitalization3.14B15.7M20,013%
EBITDA-232.67M-44.7M520%
Gain YTD11.335-12.791-89%
P/E RatioN/AN/A-
Revenue58.9M1.19M4,970%
Total Cash463M31.7M1,461%
Total Debt86.3M33.4M258%
TECHNICAL ANALYSIS
Technical Analysis
KYMRLYRA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IAXTX9.720.12
+1.25%
VY® T. Rowe Price Divers Mid Cap Gr S2
QUACX27.470.33
+1.22%
AB Small Cap Growth C
VITNX104.800.89
+0.86%
Vanguard Instl Ttl Stk Mkt Idx I
TCAGX8.970.05
+0.56%
Timothy Plan Small/Mid Cap Growth Cl C
BIREX15.170.03
+0.20%
BlackRock Real Estate Securities Instl

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.58%
NRIX - KYMR
66%
Closely correlated
+2.33%
CCCC - KYMR
57%
Loosely correlated
-2.63%
CGON - KYMR
54%
Loosely correlated
+0.82%
VERA - KYMR
54%
Loosely correlated
+1.48%
RVMD - KYMR
53%
Loosely correlated
+1.83%
More

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-3.33%
ROQAF - LYRA
85%
Closely correlated
N/A
EYPT - LYRA
58%
Loosely correlated
+0.62%
VERA - LYRA
54%
Loosely correlated
+1.48%
KYMR - LYRA
50%
Loosely correlated
+0.58%
BPMC - LYRA
41%
Loosely correlated
+0.12%
More